Literature DB >> 197017

Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

J L Virelizier, A C Allison, E de Maeyer.   

Abstract

In supernatants of mixed mouse spleen cell cultures established for 4 days, a species-specific inhibitor of virus replication with a broad antiviral spectrum was found. The inhibitor was destroyed by trypsin, was nondialyzable and acid labile, and was not neutralized by antibody to mouse L cell interferon. This indicates that in mixed lymphocyte cultures a type II interferon is made that has no immunological relationship with "fibroblast" interferon. This leukocyte product was shown to protect mouse hepatitis viruses. It is suggested that lymphocyte interferon may collaborate with macrophages in host defense against viruses, as a mediator of cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197017      PMCID: PMC421115          DOI: 10.1128/iai.17.2.282-285.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.

Authors:  K Berg; C A Ogburn; K Paucker; K E Mogensen; K Cantell
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.

Authors:  C Le Prevost; E Levy-Leblond; J L Virelizier; J M Dupuy
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

Review 3.  On the role of mononuclear phagocytes in immunity against viruses.

Authors:  A C Allison
Journal:  Prog Med Virol       Date:  1974

4.  Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

5.  Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures.

Authors:  J L Virelizier; A C Allison
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression.

Authors:  O Haller; H Arnheiter; J Lindenmann
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

7.  Neuropathological effects of persistent infection of mice by mouse hepatitis virus.

Authors:  J L Virelizier; A D Dayan; A C Allison
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.

Authors:  M J Valle; A M Bobrove; S Strober; T C Merigan
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3).

Authors:  J L Virelizier; A M Virelizier; A C Allison
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

View more
  12 in total

1.  In vitro acquisition of resistance against herpes simplex virus by permissive murine macrophages.

Authors:  K K Sethi; H Brandis
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.

Authors:  J L Virelizier; E L Chan; A C Allison
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

3.  Factors involved in the age-dependent resistance of mice infected with low-virulence mouse hepatitis virus.

Authors:  F Taguchi; A Yamada; K Fujiwara
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages.

Authors:  F Taguchi; A Yamada; K Fujiwara
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

5.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.

Authors:  M G Masucci; G Masucci; E Klein; W Berthold
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.

Authors:  R T Dean; J L Virelizier
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Abortive replication of vaccinia virus in activated rabbit macrophages.

Authors:  N A Buchmeier; S R Gee; F A Murphy; W E Rawls
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.

Authors:  E Braakman; P Treep-van Leeuwen; R J ten Berge; P T Schellekens; C J Lucas
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

10.  A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon.

Authors:  Marianne Berger Rentsch; Gert Zimmer
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.